Non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with stage ?B-? non-small cell lung cancer diagnosed by pathology or cytology; (2) Patients with negative driver gene mutation; (3) ECOG2 score; (4) PD-L1 expression level =1%; (5) Expected survival > 3 months; (6) The patient is willing to accept the treatment program and has good compliance.
Exclusion criteria
Exclusion criteria: (1) Patients with other malignant tumors in the past or at the same time within 5 years; (2) Serious heart liver kidney damage or other serious complications; (3) Exclude patients with central nervous system metastasis without systemic treatment; (4) Persons with mental disorders; (5) Have a history of multiple drug allergies allergic constitution; (6) Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Completion rate of first-line therapy;Immunologic function;TCM symptom score of lung cancer;Living quality;Objective remission rate;Security Index;Overall survival; | — |
Countries
China
Contacts
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine